Evidence check: HDL in the context of fatigue

The question of HDL (high-density lipoprotein) in the context of fatigue lacks strong scientific evidence. HDL is primarily known as 'good cholesterol' with cardioprotective effects. Some observational studies suggest an inverse association between HDL levels and chronic fatigue or exhaustion, possibly mediated by inflammation or oxidative stress. However, the evidence is weak: no randomized controlled trials demonstrate a causal link. Fatigue is multifactorial, influenced by sleep, stress, iron deficiency, thyroid function, vitamin D, and many other factors. An isolated low HDL level does not explain fatigue. In practice, HDL is measured as part of a lipid profile; values <40 mg/dL in men or <50 mg/dL in women are considered cardiovascular risk factors. Lifestyle interventions that raise HDL (exercise, unsaturated fats) may improve general well-being, but a direct anti-fatigue effect is unproven. Consumer tests marketing HDL as an 'energy marker' often overstate its significance. In summary, HDL is a useful cardiovascular biomarker but not a reliable indicator of fatigue. Persistent exhaustion warrants medical evaluation.